Reisinger Kerstin, Hoffmann Sebastian, Alépée Nathalie, Ashikaga Takao, Barroso Joao, Elcombe Cliff, Gellatly Nicola, Galbiati Valentina, Gibbs Susan, Groux Hervé, Hibatallah Jalila, Keller Donald, Kern Petra, Klaric Martina, Kolle Susanne, Kuehnl Jochen, Lambrechts Nathalie, Lindstedt Malin, Millet Marion, Martinozzi-Teissier Silvia, Natsch Andreas, Petersohn Dirk, Pike Ian, Sakaguchi Hitoshi, Schepky Andreas, Tailhardat Magalie, Templier Marie, van Vliet Erwin, Maxwell Gavin
Henkel AG & CO KGaA, Henkelstr. 67, 40191 Düsseldorf, Germany.
Toxicol In Vitro. 2015 Feb;29(1):259-70. doi: 10.1016/j.tiv.2014.10.018.
The need for non-animal data to assess skin sensitisation properties of substances, especially cosmetics ingredients, has spawned the development of many in vitro methods. As it is widely believed that no single method can provide a solution, the Cosmetics Europe Skin Tolerance Task Force has defined a three-phase framework for the development of a non-animal testing strategy for skin sensitization potency prediction. The results of the first phase – systematic evaluation of 16 test methods – are presented here. This evaluation involved generation of data on a common set of ten substances in all methods and systematic collation of information including the level of standardisation, existing test data,potential for throughput, transferability and accessibility in cooperation with the test method developers.A workshop was held with the test method developers to review the outcome of this evaluation and to discuss the results. The evaluation informed the prioritisation of test methods for the next phase of the non-animal testing strategy development framework. Ultimately, the testing strategy – combined with bioavailability and skin metabolism data and exposure consideration – is envisaged to allow establishment of a data integration approach for skin sensitisation safety assessment of cosmetic ingredients.
评估物质,尤其是化妆品成分的皮肤致敏特性对非动物数据的需求催生了许多体外方法的发展。由于人们普遍认为没有单一方法能提供解决方案,欧洲化妆品协会皮肤耐受性特别工作组为制定预测皮肤致敏潜力的非动物测试策略定义了一个三阶段框架。本文展示了第一阶段的结果——对16种测试方法的系统评估。该评估包括在所有方法中针对一组共十种物质生成数据,并与测试方法开发者合作,对包括标准化水平、现有测试数据、通量潜力、可转移性和可及性等信息进行系统整理。与测试方法开发者举办了一次研讨会,以审查该评估的结果并讨论相关结果。该评估为非动物测试策略发展框架下一阶段的测试方法优先级排序提供了依据。最终,设想该测试策略——结合生物利用度和皮肤代谢数据以及暴露因素考量——能够建立一种用于化妆品成分皮肤致敏安全性评估的数据整合方法。